Opportunities In The Home Infusion Therapy Market 2025-2035 Featuring Strategic Analysis Of Baxter International, B. Braun Melsungen, Fresenius Kabi, Medtronic, Terumo And More

(MENAFN- GlobeNewsWire - Nasdaq) The market offers opportunities through increasing adoption due to rising chronic diseases, telehealth integration, and technological advancements. However, reimbursement challenges persist. North America leads due to favorable policies and demographics. Competitive growth is driven by innovation and market expansion.

Dublin, Sept. 15, 2025 (GLOBE NEWSWIRE) -- The "Home Infusion Therapy Market by Product Type, Application, Service Model - Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025-2035" has been added to ResearchAndMarkets's offering.

The global Home Infusion Therapy market, valued at USD 36.5 Billion in 2024, is projected to reach USD 92.3 Billion by 2035, growing at a CAGR of approximately 8.8% from 2025 to 2035. This market shows a steady expansion driven by a shift towards home-based care and technological advancements in infusion therapies. Home treatment is increasingly favored due to cultural and economic benefits, particularly for chronic diseases. However, reimbursement challenges and the need for specialized staff are notable barriers.

The integration of telehealth and remote monitoring has improved patient adherence and safety, effectively reducing hospital stays. Ongoing innovation and diverse strategies involving various stakeholders are crucial for market growth.

Rising Prevalence of Chronic Diseases

Chronic diseases such as diabetes, cancer, and immune disorders necessitate long-term management and are more commonplace. Home infusion therapy offers a comfortable yet effective alternative to in-hospital treatment. Patients prefer the familiarity of home settings, enhancing compliance and outcomes. This has spurred healthcare providers to adopt home-based treatment models, facilitating global access to home infusion services.

Limited Reimbursement Policies

Reimbursement issues pose significant challenges, deterring patients from opting for home infusion therapy due to potential out-of-pocket expenses. This also impacts healthcare providers who may avoid offering such services without proper remuneration, particularly in developing regions. To foster market development, standardized and expanded healthcare reimbursement policies are essential to make home infusion services more accessible.

Integration of Telehealth and Remote Monitoring

The advent of telehealth solutions is revolutionizing home infusion therapy. Remote monitoring allows real-time tracking of patient progress, encouraging timely interventions and enhancing care quality. This shift is drawing more individuals towards adopting telehealth solutions in home infusion services, leveraging technological advancements to further improve home-based treatments.

Segment Analysis

This market analysis covers product types like infusion pumps (smart, ambulatory), intravenous sets, IV cannulas, and needleless connectors. Smart and ambulatory pumps are preferred for their medication delivery accuracy and flexibility. Needleless connectors are valued for reducing infection risks, driving product development in this segment. Special applications include anti-infective, endocrinal, nutritional support, and oncology medications. Home infusion therapy caters to various medical conditions, offering a viable home care option.

Regional Analysis

North America leads the home infusion therapy market, benefiting from advanced healthcare adoption and favorable reimbursement policies. An aging population with multiple health conditions necessitates home care services. The region's technological prowess and market representation contribute significantly to growth, with continuous efforts to enhance service offerings.

Competitive Landscape

The home infusion therapy market is moderately fragmented, marked by competitive dynamics involving innovation, service differentiation, and geographic coverage. Companies are investing in advanced infusion devices and digital health integrations to improve patient care delivery. Strategic collaborations with hospitals, pharmacies, and health agencies for home care services are emerging trends. Firms also seek to enter new markets, addressing underserved areas. Key competitive factors include customer service, delivery times, and regulatory compliance.

Companies Profiled:

• Baxter International Inc.
• B. Braun Melsungen AG
• Fresenius Kabi AG
• Medtronic plc
• Terumo Corporation
• Pfizer Inc.
• Amedisys Inc.
• Optum Home Infusion Services
• CVS Health Corporation
• Linde plc
• UnitedHealth Group Incorporated
• McKesson Corporation
• Novartis AG
• Graham-Field Health Products, Inc.
• Nipro Corporation
• Koru Medical Systems, Inc.
• Zynex Inc.
• Calea Limited

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN15092025004107003653ID1110061931